Cambridge Investment Research Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$975K Sell
26,739
-23,915
-47% -$872K ﹤0.01% 1970
2025
Q1
$1.96M Buy
50,654
+6,257
+14% +$242K 0.01% 1370
2024
Q4
$1.68M Sell
44,397
-1,244
-3% -$47.2K 0.01% 1485
2024
Q3
$1.91M Sell
45,641
-8,964
-16% -$376K 0.01% 1385
2024
Q2
$2.23M Buy
54,605
+2,240
+4% +$91.5K 0.01% 1216
2024
Q1
$2.17M Buy
52,365
+2,259
+5% +$93.6K 0.01% 1208
2023
Q4
$2.03M Buy
50,106
+410
+0.8% +$16.6K 0.01% 1191
2023
Q3
$1.95M Buy
49,696
+682
+1% +$26.7K 0.01% 1151
2023
Q2
$1.99M Sell
49,014
-621
-1% -$25.2K 0.01% 1177
2023
Q1
$2.08M Sell
49,635
-1,623
-3% -$67.9K 0.01% 1101
2022
Q4
$2.23M Sell
51,258
-2,786
-5% -$121K 0.01% 1020
2022
Q3
$2.1M Sell
54,044
-2,308
-4% -$89.6K 0.01% 999
2022
Q2
$2.39M Sell
56,352
-466
-0.8% -$19.8K 0.01% 962
2022
Q1
$2.59M Buy
56,818
+1,852
+3% +$84.3K 0.01% 990
2021
Q4
$2.67M Buy
54,966
+222
+0.4% +$10.8K 0.01% 981
2021
Q3
$2.61M Buy
54,744
+9,255
+20% +$441K 0.01% 946
2021
Q2
$2.21M Buy
45,489
+6,181
+16% +$300K 0.01% 1054
2021
Q1
$1.82M Buy
39,308
+860
+2% +$39.8K 0.01% 1062
2020
Q4
$1.83M Buy
38,448
+3,443
+10% +$164K 0.01% 964
2020
Q3
$1.5M Sell
35,005
-380
-1% -$16.3K 0.01% 960
2020
Q2
$1.44M Buy
35,385
+3,458
+11% +$141K 0.01% 921
2020
Q1
$1.15M Buy
31,927
+2,006
+7% +$72.3K 0.01% 903
2019
Q4
$1.27M Buy
29,921
+4,376
+17% +$186K 0.01% 1018
2019
Q3
$977K Buy
25,545
+1,632
+7% +$62.4K 0.01% 1084
2019
Q2
$930K Buy
23,913
+3,218
+16% +$125K 0.01% 1053
2019
Q1
$823K Buy
20,695
+911
+5% +$36.2K 0.01% 1145
2018
Q4
$721K Buy
19,784
+291
+1% +$10.6K 0.01% 1118
2018
Q3
$829K Buy
19,493
+6,837
+54% +$291K 0.01% 1135
2018
Q2
$488K Buy
12,656
+4,259
+51% +$164K 0.01% 1414
2018
Q1
$294K Buy
+8,397
New +$294K ﹤0.01% 1684
2014
Q4
Sell
-5,545
Closed -$213K 1378
2014
Q3
$213K Buy
+5,545
New +$213K 0.01% 1266